Clinical Response to Osimertinib in a Non-Small-Cell Lung Cancer Patient With EGFR L833V/H835L Mutations: A Case Report

• Main Authors: Jowan Al-Nusair MD (Author), Reesha Bodiwala DO (Author), Kemnasom Nwanwene MD (Author), Mahmoud Abdallah (Author), Mohamed Alshal MD (Author), Toni Pacioles MD (Author)
• Format: Book
• Published: SAGE Publishing, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Lung cancer, a leading cause of cancer mortality, often involves epidermal growth factor receptor (EGFR) mutations, common in 17% of Caucasian and 40% of Asian non-small-cell lung cancer (NSCLC) patients. While the exon 19 deletion and L858R mutation are prevalent, rare variants like L833V/H835L are...